An Investigation of the Importance of Patents in Academic Entrepreneurship by Himpler, Jean-Pierre
21
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ABSTRACT:
University spinouts – commercial developments out of university research – for 
many years have been growing in importance in academic research. current 
literature mainly focuses on the development of university inventions that have 
formal intellectual property (IP) protection in form of a patent. This study via 
a single case study approach qualitatively investigates the commercialisation 
process of an unpatented Maastricht University invention. Focus of the study 
is the importance of IP protection in form of a patent. The mere existence 
of a patent – so reveals this research – does not seem to primarily influence 
measurable business outcomes. since the research was designed as an 
exploratory, qualitative single case study with additional interviews, the afore-
mentioned results need to be tested on a larger scale.
KEYWoRds: spinout, academic entrepreneurship, patent, IP protection, 
(l26, o32, o34).
Introduction and Research Question
Previous studies have revealed that the capitalisation of academic research is 
getting more common, due to potentially high profits (Markman, Phan, Balkin, 
& Gianiodis, 2005). current studies focus mainly on the commercialisation of 
scientific inventions that are protected by patents (e.g.: Abreu & Grinevich, 2013; 
shane, 2004). This study investigates first, IP protection and second, as suggested 
by Fini, lacetera and shane (2010) the effects of non-formal IP protection 
only on business development. The single case investigated in this study is the 
commercialisation process of a Maastricht University (UM) invention. 
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The case study
The undertaken investigations were designed as a single case study in the 
field of medical technology (MedTech). The product is an artificial vestibular 
system (Avs) in form of a belt that brings spatial coordination to people who 
lack the feeling of balance. The developing professor behind the invention is 
an otorhinolaryngologist and a well-known specialist in the field of balance 
and the vestibular system. He supports several research projects especially 
in the field of vestibular difficulties. one of his research ideas is an external 
artificial vestibular system (Avs) in form of a belt developed for people with a 
bilateral vestibular loss. The idea of a belt to train spatial orientation based on 
vibrotactile feedback is not new, already since 2003 BalanceTek holds a patent 
for a similar type of balance prosthesis in the United states of America (UsA).
Maastricht Instruments (later referred to as technology transfer office, 
TTo) is a company owned by the UM Holding with the goal of commercialising 
on scientific inventions of UM. Besides investigating licensing opportunities 
for products developed by UM with already existing companies, the TTo also 
intends to support the development of new companies founded around the new 
inventions. Throughout the research process – collaboration over eleven months 
– the TTo supported the business case creation via a business developer, who 
served as a collaboration partner, and also a range of consultants. To facilitate 
support for the business case creation process there was also collaboration with 
the regional development agency (RdA), which additionally offered a support 
program to cover training and business case development costs.
Research Question and its Relevance
The development of university spinouts is a topic of growing academic inte-
rest (e.g.: Abreu & Grinevich, 2013; chatterjee & Rossi-Hansberg, 2012; Fini 
et al., 2010; Grimaldi, Kenney, siegel, & Wright, 2011; Malik & Mahmood, 
2012; Perkmann et al., 2013; shane, 2004). core focus of the paper is to find 
out whether and to what extent IP protection in form of a patent is important 
for business success. The following research question evolved:
‘How does the absence of IP protection in form of a patent influence the 
commercialisation of scientific inventions out of university research (academic 
entrepreneurship)?’ In order to develop an academic theory, the research in this 
study is designed as a single case study based on observations, focus groups, 
interviews in the case (researchers, technicians, business developers at Maast-
richt Instruments (MI), manager of another spinout of Maastricht University 
which was founded in 2011, Xilloc Medical, 2014) and additional interviews 
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that support the theory development but are not directly linked to the case 
(medical specialists, managers of non-MI spinouts). Before the collection and 
analysis of field research data, the existing literature related to AE and patent-
ing was reviewed in order to set a context into which the study can be placed. 
The study due to its scope ignores the question of who should own the IP, 
since the variety of ownership and contractual structures is too manifold to be 
covered in the small-scale size of this research. 
Objectives and Structure
The research is organised in three objectives. First, the literature was analysed 
with regard to different forms of capitalisation of academic research. The focus 
lays on university spinouts. second, the study focuses on the importance of 
IP protection in form of patents. Emphasis has been put on the lack of patent-
protection and its influence on success. Third and last objective of this study 
was the development of recommendations for the continuation of the case, as 
much as for the future of AE research with regards to patenting.
Literature Review
“Universities are pressured to show tangible returns for the research grants 
they receive” (Baldini, 2010, p. 872). The purpose of research, however, 
should be an “abstract desire for truth” (1918, p. 526) which stands in contrast 
to the solution of a society problem which is the basement for the commercial 
exploration of a product (Pittaway, 2012). As a consequence, the potential 
creation of revenues and profits out of research results is based on a range 
of tensions, which have to be overcome. Revenues can be generated via pa-
tenting, licensing and spinout creation. Whereas patents and licenses keep the 
ownership of IP in-house, the creation of a new business can also mean that 
the rights of the IP move from the university to the spinout (McAdam, Miller, 
McAdam, & Teague, 2012; Wright, clarysse, Mustar, & lockett, 2007). Patent-
ing only means that the way something functions is protected. It does not mean 
that the patent is used and that any revenue is generated with it. “licensing 
has traditionally been the dominant route for the commercialisation of public 
sector IP” (lockett, siegel, Wright, & Ensley, 2005, p. 982). It implies, that 
the right to exploit IP – whether protected by a patent or not – is given to a 
company which makes use of the research results and somehow shares its 
profit with the university (shane, 2004). The alternative to licensing is the 
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entrepreneurial approach, namely the creation of university spinouts or AE. 
The development of spinouts has increasingly been supported by governments 
in Asia, the UsA and Europe (Baldini, 2010; Kroll & liefner, 2008; Moray & 
clarysse, 2005; Wright et al., 2007; Yang, chang, & chen, 2006). 
Academic entrepreneurship (AE) and its stakeholders
Given there is still is no common definition for AE, AE in the context of this 
study needs to be defined. It is the creation of university spinoffs which are 
new businesses founded to commercially exploit IP, which was developed at 
an academic establishment (e.g.: di Gregorio & shane, 2003; djokovic & 
souitaris, 2006; Roberts, 1991; van Geenhuizen & soetanto, 2009). Here 
spinouts based on research with or without IP protection in form of a patent 
and with or without the initial researcher to be part of the business are included.
Figure 1: Stakeholders in academic entrepreneurship
(no main source, Friedman & Miles, 2006; lockett et al., 2005; Malik & Mahmood, 2012; 
McAdam et al., 2012; Meyers & Pruthi, 2011; Roberts, 1991; shane, 2004)
In AE there is a range of stakeholders as visualised in figure 2.1.  Given the 
increased economic interest in the commercial exploitation of university 
research (lockett et al., 2005), technology transfer offices (TTo) are getting 
more and more common (Algieri, Aquino, & succurro, 2013; Hülsbeck, leh-
mann, & starnecker, 2013; Markman et al., 2005), a unit that is enhanced 
by university leadership (Meyers & Pruthi, 2011). These come not only with 
advantages for the entrepreneur, as they as additional intermediary also need to 
be financed resulting in an increased economic interest of the university. This 
Academic 
Entrepreneurship 
Stakeholders
Entrepreneur (Shane, 2004; Malik & Mahmood, 2012; Meyers & Pruthi, 2011)
Customer (Friedman & Miles, 2006; Meyers & Pruthi, 2011) 
Researcher Team (Shane, 2004; Malik & Mahmood, 2012; Roberts, 1991)
Specialists (Shane, 2004)
TTO (Lockett et all, 2005; McAdam et al., 2012) & university leadership
 (Meyers & Pruthi, 2011)
RDA (McAdam et al., 2012)
Sources of Finance (Friedman & Miles, 2006; 
 McAdam et al., 2012; Shane, 2004)
Consultants (Lockett et all., 2005)
Competition (Friedman & Miles, 2006)
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interest though by definition stands in conflict with academic goals as there is 
an on-going “tension between encouraging entrepreneurship and encouraging 
and rewarding pure academic activities” (Philpott, dooley, o’Reilly, & 
lupton, 2011). This conflict resulted in the stakeholders to be structured in 
business and technical specialists from an internal and an external perspective. 
The stakeholders from figure 2.1 were grouped as presented in figure 2.2. 
The allocation of the subjects to the groups is neither exhaustive nor mutually 
exclusive (e.g. other spinout managers could also be classified as internal; the 
customer, the potentially most important stakeholder (Meyers & Pruthi, 2011) 
is totally missing in the visualisation). The entrepreneur (the chief executive 
officer (cEo) of the new company) as one of the core stakeholders (e.g.: Ma-
lik & Mahmood, 2012; Meyers & Pruthi, 2011; shane, 2004) is placed in the 
middle, because he links all other stakeholders together
Figure 2.: Stakeholder analysis matrix
(no main source, stakeholders from: lockett et al., 2005; Malik & Mahmood, 2012; 
McAdam et al., 2012; Post, Preston, & sachs, 2002; Roberts, 1991; shane, 2004)
Internal Specialist:
Researchers (Shane, 2004, Malik & 
Mahmood, 2012; Roberts, 1991), 
Technicians (Shane, 2004)
Internal Business:
TTO (Lockett et all., 2005, McAdam 
et al., 2012), 
Internal finance from University 
(Shane, 2004)
External Specialist:
Specialists on the field 
(Shane, 2004)
Specialist
Business
Entrepreneur (e.g.: Malik & Mahmood, 2012)Internal External
External Business:
RDA (McAdam et al., 2012), other 
spinout managers/medical 
entrepreneurs (Post, Preston, & 
Sachs, 2002), Venture capitalist/
business angel (McAdam et al., 2012), 
consultants (Lockett et all., 2005)
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Knowing the many stakeholders there are, stakeholder salience should be 
investigated based on three stakeholder’s “relationship attributes: power, 
legitimacy and urgency” (Mitchell, Agle, & Wood, 1997, p. 853). Applying 
this framework to the stakeholders shown in figure 2. The competition is a 
latent stakeholder, the research team, specialists and consultants are expectant 
stakeholders and the TTo, the RdA, financiers and customers are highly 
salient stakeholders. Management should especially focus on highly salient 
stakeholders as they can really influence the business.
Patents and their importance
Patents are defined as: “a government authority or licence conferring a 
right or title for a set period, especially the sole right to exclude others from 
making, using, or selling an invention” (oxford dictionaries, 2014). In the 
context of AE research primarily looks at IP protection in the form of patents 
(shane, 2004). However, other forms of IP protection such as trademarks and 
copyrights also exist (Bradley, Hayter, & link, 2013). It seem that there is a 
development of IP management more towards handling it as a strategy rather 
than a purely protective approach in terms of patenting (smith & Hansen, 
2002). Further, the company owning the patent is also in charge of supervising 
the market for patent violations. This can be a particularly costly duty since 
all the knowledge behind the IP is publicly disclosed at the moment of pa-
tent application (Markman, Gianiodis, & Phan, 2009). In case a patent is not 
granted, the disclosure of information to the competition can be a severe cost 
to the company that developed the invention. For general entrepreneurship 
and other businesses not acting in straight connection to academia, smith 
and Hansen (2002) explain that IP can also be protected by non-disclosure. 
However, shane (2004, p. 259) finds out in research interviews with MIT 
spinoff managers, that patents are perceived as the key business success 
factor – thus this study is an attempt to fill this knowledge gap. The authors 
further state that “it takes real aggressive, competitive IP management […] to 
succeed” (shane, 2004, p. 259). From an economical perspective, a patent can 
be compared to an investment and the decision for it to an investment decision 
with a clear business case (smith & Hansen, 2002). For now, the research 
about AE without patents is very limited. This study explores how important 
the existence and use of a patent is in the context of AE and thus tries to closing 
this subject-related gap.
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Research Design and Methodology
The primary research that is used to evaluate the importance of patents as 
IP protection tools at the example of the Avs is explained in this section. 
This qualitative study is an exploratory one. Knowing that the field of 
entrepreneurship is a fairly new academic field (Pittaway, 2012), it is still 
necessary to develop theory which can be tested in future more quantitative 
research. A spinout development process has been accompanied over a period 
of eleven months. The research cannot be classified as longitudinal, though it 
has some longitudinal elements.
Research techniques in use
To fully explore the case and as academia sees entrepreneurship as “too 
dynamic and complex to be captured by a single method” (Neergaard & Ulhøi, 
2007), some of the many methodological varieties that exist within qualitative 
research have been applied (saunders, lewis, & Thornhill, 2012), meaning that 
triangulation was used (Bøllingtoft, 2007). This latitude of qualitative research 
(Yin, 2011)  allowed ford different angles of analysis and objectification of the 
multiple realities of human cognition (saunders et al., 2012). Phenomenology 
(Goulding, 2005) permitted the full exploration of IP protection importance.
due to the research setting and the limited time frame for the study, it was 
not possible to give all research subjects equal importance. Particularly more 
observation effort has been put into the collaboration with and the research of 
subjects of primary importance for the commercialisation of the product. The 
consequently more thorough understanding of those allowed differentiating 
between personal opinions and right answers with regards to the duties 
they perform. The use of observation and focus groups primarily resulted 
in discussions, in which the researcher took more the role of a moderator, 
rather than asking specific questions. For the mostly unstructured interviews 
discussion areas were predefined to ensure that follow up questions were topic-
related (Yin, 2011).
Internal, related and external perspectives
To minimize sways by the researchers prolonged collaboration with the TTo, 
not only the internal perspective from within the study, but also the external 
perspective has been investigated. In group three and four of Table 3.1 internal 
does not mean that the subjects come from within the university or the TTo, 
but that they closely monitored the development of the Avs business case 
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over a prolonged period of time and thus can form a neutral but case-specific 
opinion. The salience of the different stakeholder has been a factor of choice 
according to which research subjects have been investigated. specialists 
around the case – especially other academic entrepreneurs – were met to get a 
better understanding of the research results. As some of the examined subjects 
were in between internal and external, a third category – related – has been 
introduced. In order to avoid any influence of the subjects by the researcher, 
unbiased wording was used in all communications (saunders et al., 2012). 
A mix of recording and detailed notes taking has been used which allowed 
for focusing on aspects such as body language (Maylor & Blackmon, 2005; 
saunders et al., 2012; Yin, 2011).
To structure the study in the best possible way, the many investigated 
subjects were grouped as visualised in table 3.1, which was developed out 
of figure 2.2. Whereas the figure only differentiates between Internal and 
External, and business experts and medical or technical specialists, the table 
is more detailed being based on the specific setup of the case. As explained 
above Internal and External was adapted to Internal, Related and External 
allowing for a better categorisation of the subjects. To facilitate the reader’s 
understanding of the subject all codes are structured like table 3.1. The codes 
start with Internal (I), Related (R) or External (E), and go on with the first 
letter of the respective group and then are counted through. A hyphen after 
the I, R or E prevents confusing the coding with other abbreviations. In order 
to give the many subjects and events a more systematic grouping the business 
has also been classified in other categories. Table 3.1 shows all subjects that 
have been actively involved in the study and have contributed to the academic 
development of the paper.
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Table 3.: Grouping of Research SubjectsResults
This section is designed to present the results of the investigations. The 
respondents and consequently the following sections were grouped as 
visualised in table 3.1. 
Internal Related External
1. Specialists Researcher (I-S1)
Assistant of Main 
Researcher (I-S2)
Technician in Research 
Study (I-S3)
Professors and 
technical specialists in a 
focus group (R-S)
2 craniosacral 
specialists (E-S1a-b) 
and 2 physiotherapists 
(E-S1c-d) in a focus 
group
Osteopath (E-S2)
Orthopaedist (E-S3)
Otorhinolaryngologic 
practitioner (E-S4)
2. Business 
side
Business developer 
TTO 
 Longitudinal 
observation (I-B1)
TTO Manager (I-B2)
investment bank 
Advisor (R-B)
Kamer van Koophandel 
(E-B1)
RDA (E-B2)
3. Academic 
Entrepreneur
Business developer that 
takes a current product 
further (I-AE)
–
2 CEOs of med. 
companies based on 
software (see, E-AE1-2)
7 CEOs of med. 
companies not based 
on software (see table 
4.4, E-AE3-9)
Operations manager 
of a med. company 
(E-AE5a)
4. Finance
Informal Angel Investor 
who almost invested 
(I-F1)
Financial specialist 
(I-F2) 
Interregio Conference, 
Limburg, Netherlands 
(R-F1)
European Venture 
Contest, Aarhus, 
Denmark (R-F2)
Venture Capital Senior 
Manager (E-F1)
Med. Consulting 
company: Senior 
Consultant (E-F2) 
Angel Investor and CEO 
(E-F3)
5. Lawyer, specialization Patent Law
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Specialists
A broad range of specialists including the researcher who developed the product, 
as much as companies in the field and completely independent specialists in the 
medical field. They were investigated as much in interviews as in focus groups 
(see Table 3.1). Even when getting specific questions about patenting none of 
them apart from the researcher that developed the product cared about whether 
the product did have a patent or not so. All specialists were primarily interested 
by the medical validity of the product. depending on whether the specialists 
were working in research or commercially the price of the product for the final 
patient was an issue of importance. 
Business development
Internal Business focus
Internal subjects are part of the TTo. For the investigations of the business 
partner at the TTo, two research techniques have been used: interviews and 
observation. The business developer (I-B1) was observed and interviewed in a 
mostly unstructured way at several points in time. Next to that an unstructured 
interview with a manager of the TTo (I-B2) has been undertaken. I-B1, no 
matter what happened was all the time extremely positive about the development 
of the Avs. When a consultant (I-c2) expressed his disbelief in the product, 
collaboration with the consultant was not continued, rather than revising the 
own opinion. When specialists (E-s1a-d, E-s2, E-s3) considered the product 
not to be competitive their opinions were considered as “interesting”. At a later 
point in time, one possible investor (I-F1) assessed his network of potential 
partners for commercialising the invention. When several of his possible 
partners independently explained him, that the market of bilateral vestibular 
loss is very small, and that the product cannot be applied e.g. in fall-prevention, 
the investor – so explained I-B1 – wasn’t matching the product. Even though 
I-B1 had a business background, he was persuaded by scalability assumptions 
that according to a consultant (I-c3) have proven wrong in business many times 
(I-B1: “We sold five belts, thus, there is a market to sell it to”). However, all 
statements by I-B1 are to be considered relative to his own statement of being 
an intrapreneur rather than an entrepreneur and the fact that he is employed, 
and so – as explained I-F2 at a later stage – needs to have the opinion of the 
business that employs him (the TTo). 
The unstructured interview with a higher manager of the TTo (I-B2) has 
revealed the conditions of the TTo for the technology takeover of the Avs. 
comparing these conditions to conditions other academic entrepreneurs knew 
31An Investigation of the Importance of Patents in Academic Entrepreneurship
from other universities (I-AE, R-AE1) the earning expectations of the TTo 
at university where the Avs has been developed were much higher than the 
earning expectations of other universities. According to I-B2 “the TTo is a 
totally separate non-academic unit which is a profit-oriented business”.
Related Business focused subjects
In the category related, there is one advisor from an investment bank (R-B) 
whom was met with several times. Topic of conversation was more the global 
business perspective than financial aspects; therefore, he was categorised as one 
of the business-focused subjects. The subject knows the Avs and influences 
its development (either in form of advice or future funding), wherefore the 
group related was chosen. An unstructured interview with a consultant from 
an investment bank (R-B) revealed that the existence of a patent influences 
funding only to a limited extent. If the product is easy to copy then patenting is 
good, if the product is very elaborated, though, patenting is a danger. As patent 
information has to be disclosed the general public – including competitors – 
gets access to years of research at no risk and no cost.
External Business focused subjects
The category external includes a meeting with the chamber of commerce (E-
B1) for general information and the attitude of the RdA (E-B2) regarding the 
development of new technology driven businesses in the region. These subjects 
are neither influenced by the commercialisation plans nor monetarily involved 
in the Avs development.
consultant chamber of commerce (E-B1): “Be the decision taker, be 
sure to own the majority of the business!” The exploration of entrepreneurial 
opportunities around the Avs involved contacting the chamber of commerce. 
Their advice though, did not match the meaning of success in this study. 
Here success is defined as quantifiable business accomplishments; the above 
recommendations were linked to the realisation of the entrepreneur as such. 
E-B1 agrees with previous subjects on the importance of patents to depend on 
the product.
Representative of the RdA (E-B2): “The business plan is what counts for 
us. If it is valid, then we deliver support!” one of the subjects in the study (E-
B2) represented the RdA. E-B2 generally agreed with the consultant from the 
investment bank (R-B) regarding the importance of patents. Both subjects (E-
B2 and R-B) mentioned this independently and explained that patents are only 
marginally – if at all – affecting collaboration with a new business. like many 
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others, E-B2 mentions market size and the entrepreneurial team to affect the 
success of AE. 
Academic entrepreneurs
Internal academic entrepreneurs
one entrepreneur working on a product from the same TTo (I-AE): “The 
importance of patenting depends on your product.” There is only one subject 
that falls into this group, which is an entrepreneur that currently brings an 
invention from the same TTo to the market (I-AE). The invention he works 
on is not patented either, wherefore the comparison of the two cases seems 
interesting from an academic perspective. I-AE considers two aspects to be of 
crucial importance for his business: the widespread network of the TTo and 
the non-disclosure of his algorithms. The device this entrepreneur is bringing 
to the market is a movement monitoring system. He explains that only the 
network of the TTo makes the commercialisation possible. Patenting – so he 
says – would rather harm his product because the disclosure of his algorithms 
would have negative consequences.
Related academic entrepreneurs
Two cEos can be categorised as related to the Avs. one is the founder 
manager of a previous successful spinout of the same TTo (R-AE1) and the 
other one is the cEo of a competing MedTech company (R-AE2). The second 
company’s cEo knows the Avs fairly well and is involved in decisions about 
future funding programs such as the one that was received for the Avs; R-AE1 
was also part of the program. 
Previous spinout manager: “You have to love something about it, no 
matter if that’s the product, the figures, the selling, you have to live it, to breath 
it!” R-AE1 emphasised that the all-deciding factor is not the patent but the 
enthusiasm of the entrepreneur. He explains that if the entrepreneur is not a 
charismatic driver then the company cannot succeed. This, so he emphasizes, 
is the most crucial aspect. Patents, according to him, “are only necessary to 
catch investors, nothing else”. They are important but primarily as a manage-
ment strategy rather than as a tool for protection.
R-AE2 was talked to after holding a presentation about his own company. 
His company focuses primarily on research for laboratory technology and sells 
to large companies who commercialise on his inventions. R-AE2 explained the 
importance of patents, stating – similar to other subjects – that it is a balance 
act between keeping information in-house and disclosing it. Furthermore, he 
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justifies that it is a much bigger challenge to monitor the market and competition 
whilst doing research. Researching or patenting a solution to a problem which, 
by the time the solution is found, does not exist anymore – so he concludes – 
does not make sense.
External academic entrepreneurs
overall nine cEos and one operations manager of nine different medical 
companies were communicated with especially focussing on the importance 
of IP protection in medical entrepreneurship. Full comparison cannot be made, 
because the input of the different respondents varied significantly in length 
and completeness. All of the selected businesses developed out of previous 
research at academic institutions. The major point for deciding whether or not 
the involvement of a patent was advantageous – several of the subjects clarified 
– were whether algorithms were involved, and whether the product was 
software-based or not. Therefore, the study differentiates between software-
based respondents (E-AE1 and E-AE2) and not software-based respondents 
(E-AE3 to E-AE9). The cEos of the two software-based devices emphasised 
different aspects that influence the success of a new company – one did put the 
focus on the market’s needs (E-AE1) and the other on the representation and 
sales capabilities of the entrepreneur (E-AE2). still, they agreed on one aspect 
– the patent to be a danger to business. Revealing the algorithms behind their 
software – so both describe independently – is rather harming the business 
development of their products. Whereas the opinions of the cEos of companies 
with software-based products were fairly similar, the opinions on patenting in 
non-software-based businesses were widespread. According to E-AE4 all his 
companies have patents, which makes it possible to get investors. He makes 
clear that patents are necessary to catch investors. E-AE5a elaborates on pa-
tenting that in his company most products successfully combine several paten-
ted parts wherefore the entire products become unique. For E-AE7 the lack of 
patenting turns out to be a problem: “our device is too simple to be patented 
and that is why we don’t get investors.” The simplicity of the device and the 
lack of the patent – so clarifies E-AE7 – make the device so easy to be copied 
that investors don’t want to go for the risk. This entrepreneur questions the 
free market as a consequence: most of the products – also the successful ones 
– do not have relevant patents and many still succeed. This refers to R-AE1s 
statement about patents to be important to get investors. R-AE1 does have a 
patent, however, his patent is not linked at all to the unique selling point (UsP) 
of his firm. As for success influencing factors E-AE5 repeats the opinion of 
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R-AE1 to a certain point. He agrees with R-AE1 that belief in the product 
and the enthusiasm of the entrepreneur is decisive. Further E-AE5 – who, 
several years ago, was about to shut business – concludes that it is crucial 
to continue even in phases, which do not look promising. The most detailed 
conversation and advisement happened with E-AE9 who took much more 
time to discuss the Avs. E-AE9 has a special connection to the Avs given 
he worked as a business development manager at the TTo of the Avs. He is 
here classified as external because his opinion is absolutely neutral. At his time 
at the TTo, the Avs was already under development, however E-AE9 only 
knew about the existence of the product. E-AE9 by today is an entrepreneur 
in a team of three and as he explains, they bring it all together, management, 
market and technical knowledge. As for patents the opinion of E-AE9 was 
relatively rigorous. He explains that a patent is only useful if it can be defended 
and in case it is expected to earn substantial returns. Even though a patent 
secures knowledge that is unique it is neither a protection a defence, nor a 
prove of unique technology. Positives of a patent are, the freedom to operate 
and consequently it makes the company an interesting partner because the 
company is not only based on public knowledge.
Finance
This section includes subjects that were interviewed at several points in time 
and also conversations at a national and an international finance event. 
Internal finance
I-F1: “Only when fully being part of the story it is possible to develop a 
really unbiased entrepreneurial opinion” one of the investors (I-F1) can 
be categorised in the group of internal finance because he went into making 
research to find out more about the Avs. His investigations of an entire network 
of specialists, consultants and business people revealed, that it is better to stop 
any further investments in the business creation process around the Avs, as 
long as medical validation studies are not completed. With this validation – he 
justifies – the Avs can be a success. Knowing that the market for this product 
is uncommonly specific, it is very small and hence difficult to reach. due to 
the extremely limited size – so he explains – only a very broad international 
approach by a large company can work out. small new companies according 
to him could not handle the necessary commercial representation of the 
device. As for the importance of patenting I-F1 explains that patenting is only 
important from the perspective of the investors. I-F1, himself a business angel, 
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explains that investors are by definition limited in their knowledge. A patent 
gives investors the feeling of exclusivity, which as a consequence raises their 
assumption that the product definitely can be commercially explored. other 
than for this reason a patent is not necessary because for most companies it 
is not possible to cover the follow-up costs of a patent. For new companies 
patenting only attracts investors. With patent or without, if there is a mana-
gement team that covers the companies needs as much from a specialist as 
from a business perspective and if the product really solves a problem, then 
commercial success is very likely. The accountant (I-F2) made rather general 
statements due to limited case-specific knowledge. He specifically elaborates 
on the massive follow up costs of patents. Next to paying very high patent 
fees the market needs to be continuously monitored whether competitors try 
to abuse the knowledge of one’s patent. The monitoring as such is very costly 
and then one also needs to have the financial buffer zone to pay for the legal 
costs until the case is won. considering all the costs it might – especially for 
new and small businesses like the potential company for the Avs – be a good 
decision to take the risk and not patent the product. Patenting for a new busi-
ness should only be an option if it is very likely to succeed large scale, which 
is unlikely for the Avs, due to the small market size.
Related finance
In related finance no people can be mentioned, yet the collaboration with 
the TTo and the RdA have made it possible for the researcher to participate 
in two events: the Interregio conference limburg (R-F1) and the European 
venture contest Healthtech denmark (R-F2). R-F1 was a regional event where 
entrepreneurs could present their inventions. At the event several inventions 
were presented by entrepreneurs, which were about to bring the respective 
products to the market. Business angels, investment companies, local journalists 
and managers of businesses in the healthcare industry formed the audience. At 
the event the presentation of the Avs caught the interest of several potentially 
collaborating companies and also I-F1, a major regional business angel, whose 
opinion was elaborated upon in section 4.5.1. The European venture contest 
Healthtech (R-F2) is one of the biggest MedTech events in Europe. Roughly 
thirty relatively new companies pass the complex participation-application 
procedures every year; this year amongst these, the Avs. The researcher-
entrepreneur presented the Avs at the event to an audience of international – 
primarily European cEos, venture capitalists, business angels and consultants 
which evaluated the investment pitches of the presenting businesses. The – at 
36 Gazdaság & Társadalom / Journal of Economy & Society – 2018/2.
the time – planning was criticised because of a lacking non-medical approach 
towards the product. The missing long-term perspective was also not considered 
positive. Furthermore, the medical validation was and is missing, which makes 
long-term business planning for the Avs deceitful.
External finance
E-F1: “Taking decisions is about facts – but in entrepreneurship and investment 
this is also a lot about feelings!” Three subjects fit in the group of external 
finance, namely a senior venture capital manager (E-F1), a senior medical 
consultant (E-F2) and a cEo and Angel Investor (E-F3). At R-F2 in denmark 
the Researcher Entrepreneur got to know E-F1 and E-F2. Both subjects were 
talked with independently about the Avs and also the importance of patents in 
AE. Both independently commented on patents, no matter what they protect to 
be good in attracting investors. However, there was certain disagreement about 
their success importance. Whereas the consultant (E-F2) explicitly commen-
ted upon the patent not to be of crucial importance in case the product had any 
algorithms involved. The venture capitalist (E-F1) did not comment on the 
patent at all – even though several questions about it were asked. E-F3 was a 
contact made via I-B2. E-F3 – himself an entrepreneur in several businesses 
emphasised in particular on the importance of the focus of the entrepreneur. 
different to I-F1 this investor did not give patents a major importance, but 
primarily saw them as major cost.
The patent lawyer
Granted the many differing opinions on the importance of patents a patent 
lawyer was consulted to explain why and when patenting is relevant or 
helpful and what is important about it. Given his legal perspective there was 
no business focus in the questions other than the questioning about the busi-
ness consequences of any suggested legal actions. His statements were not 
contradicting any of the previously mentioned comments or opinions by other 
subjects, though rather explained the reasons. According to the patent lawyer 
it is not the existence of a patent but no matter what is patented depends on the 
quality of the patent which is decisive. A very good patent would be one that 
patents a whole process, a very bad one, one that protects a certain shape of a 
part. The lawyer elaborates that there are many complicated ways to fight for 
one’s right on the patent, however either one of them is very costly. The lawyer 
comments as I-F1 beforehand that patents are more useful to the big players 
rather than small new companies. 
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Discussion & Conclusion
This section serves as a sum up of the results and as a comparison of these 
with the literature and already existing theory. The chapter is divided into two 
sections: 1. Importance of a patent, 2. conclusions and Recommendations. The 
first of the two sections combines the knowledge presented in figure 2.4 with 
the results, which were illustrated in the previous chapter. The second section 
closes chapter with key conclusions and key recommendations for academic 
entrepreneurship, the investigated case study as much as the continuation of 
academic research.
The importance of a patent
This study revealed that at the base there are mainly two options for IP in 
academic research: To fully disclose it and to patent it, or not to disclose it and 
to keep it exclusive to a limited few. The majority of respondents (R-B, E-B1, 
E-B2, I-AE, I-c1a, I-c1b, I-c2, R-c2, E-c1, E-AE9) explained that patenting 
necessities cannot be generalised but are product dependent. In accordance 
with the literature (shane, 2004), it was explained that patenting could be 
an advantage (R-B, E-B2, E-AE9, I-c2, E-c2, E-c3, I-F1), but it was not 
mentioned a single time in the study, that patenting is the paramount success 
influence. The only specific case – two subjects mentioned independently – in 
which patenting definitely is preferential is, if the product is very simple (I-B1, 
E-AE4). If patenting is definitely the way to go, then a good way to choose 
might be to combine several patented parts to become a unique combination 
(E-AE5a, E-AE9). other than the patent lawyer, no-one thought that the 
inexistence of a patent might have strong negative effects on the business per-
formance of the company; in fact some perceived patenting as unnecessary (E-
AE1, I-c3), several subjects independently explained that patenting is a danger 
due to the disclosure of information (I-AE, E-AE1, E-AE2, E-AE3, E-AE9, 
I-F2); a fact that seems especially to be valid in software-based companies 
(I-AE, E-AE1, E-AE2). In fact, several times entrepreneurs and consultants 
alike linked the question of patenting linked to the product being based on 
software or not. some respondents explained that patenting is not important 
(I-c3, R-c, E-F3) and can be hindering business (I-B1, I-B2, I-c3). This is 
the case, because focus moves away from value-creating activities to mar-
ket monitoring for infringements; competition can also be good for business. 
Whether the opinions of I-B1 and I-B2 in this respect are truly own opinions, 
or if their comments are linked to the fact that the Avs does not have a patent 
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is unknown. Good or bad, it is found – just like shane (2004) explained – that 
patenting comes at its price. Next to high-end fees for the patenting authorities 
(I-c1b, R-c2, I-F2) there are also large follow-up costs associated with mo-
nitoring the market (E-AE9, I-c1b, I-c2, I-c3, E-c2, I-F2). It seems to only 
make sense to patent simple inventions because the costs linked to monitoring 
and protecting a complex patent often outrage the potential earnings that can 
be achieved via the patent. Be that as it may, patents do have a plus; they are 
a proof of unique technology, grant freedom to operate (E-AE9) and serve for 
getting investors (R-AE1, E-AE4, E-A7, I-F1, R-F2, E-F1, E-F2). Apparently, 
patents are so important to investors, that one of the interrogated entrepreneurs 
R-AE1 even chose to go for a patent, which does not protect his UsP. The 
positive consequences of patenting – so revealed the discussion with the patent 
lawyer – depend solely on the patent quality. It cannot be generalised what the 
best choice is, but it seems that in most cases the disadvantages of patenting 
overweigh its advantages. only if the patent is of high quality and protects 
the upmost range of options it can be of advantage. Nevertheless, also high-
quality patents come with challenges.
Table 5.: Patenting evaluated
This study has proven that current AE research does not treat inventions, which 
do not enjoy the protection by a patent with the necessary care. It was found 
that patents, trademarks and copyright exist, but that in fact only patenting 
is understood as an IP protection tool. In AE there are two main choices for 
treating IP: pure non-disclosure of information and the management strategy 
Advantages of the patent Disadvantages of the patent
IP protection
Attractive to investors
Good for very simple products
Freedom to operate
Proof of unique technology
High costs for patenting
High costs for following up on patent
Information disclosure can be risky
Can be hindering business
Does not protect, just gives legal means
Consequently: Not the paramount success determinant
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of a product (as mentioned by I-AE, E-AE9) including key opinion leaders as 
a form of protecting IP. Patenting means full disclosure of the idea.
Conclusion & Recommendations
This study clearly reveals at the example of the Avs and especially the 
surrounding interviews that practitioners do not see patenting as an absolute 
necessity for success. Nevertheless, patents do play an important role also in 
the field of AE because they influence the decision-making of a highly salient 
stakeholder: the investor. This study makes recommendations for the field of 
AE, the particular case of the Avs and for future research.
The General Importance of Patenting in Academic Entrepreneurship
This study reveals that patents are not decisive for success; IP protection is a 
strategy. Patents come at a high price and with major follow-up costs; only 
high-quality patents are of advantage, but the IP disclosure associated with 
patenting can be risky, especially for software-based products. Patenting for 
protection seems to only make sense for very simple products or for products 
that are exploited on a large scale by large companies, as they are a legal 
defense tool against large competitors. small companies mostly do not have 
the monetary breath to fight for their rights against large competitors. The 
options always are: patenting or not disclosing information – the later might be 
a good choice if algorithms are involved. To protect business, it always makes 
senses to create a system that only works when several matching parts from 
the same company come together. From an expenses point of view, the costs 
for patenting only make sense if large revenues and earnings are expected. In 
AE patents seem to be of minor importance as a protection tool, however, they 
grant freedom to operate and so make the starting business an interesting part-
ner, not only from an investor’s perspective. It cannot be said in general that 
university spinouts have to have patents, this always depends on the product.
The Importance of Patenting in the Investigated Single Case Study
The study clearly shows that the lack of a patent is not a disadvantage in the 
case of the Avs however small the market might be. continuation of the 
commercialisation is possible – whether the best option is a new company, 
however, is not sure. Recommendations of I-F1 seem to lead to the conclusion 
that the Avs is particularly interesting for larger companies who can easily 
tap the larger scale marketing channels and who are interested in a license 
deal. All in all, development is still necessary prior to commercialisation. 
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currently medical validation is still pending, pursuant to I-R1, it is just about 
to be received; an inalienable necessity for exploiting the medical market. 
Nevertheless, a cooperative angel investor who especially aims for helping 
people which are suffering from bilateral vestibular loss might bring this 
product further and could be key in case of the creation of a new spinout. For 
commercialisation primarily focusing on quantifiable return, licensing might 
be the best option.
Limitations and Future Research Recommendations
This study is an exploratory research study based on a single case study only 
focusing on patents. Therefore, several limitations evolved. 
1. Key success factors in Academic Entrepreneurship: The key result of 
this study is, that a patent does not belong to the core success influencing 
factors in AE. A separate study about what the key success factors in 
AE actually are is necessary.
2.  Not generalizable results – test results in future research: The conclusions 
about the importance of patenting drawn from this research project 
are not fully generalizable to AE as a whole, but only to a theoretical 
proposition. Yet, shane (2004)’s reasoning for patenting to be a key 
success determinant is put in question. Nevertheless, the importance of 
patenting must be tested in future quantitative research. 
3. Make maximum use of provided data: This research had – particularly 
due to limitations in pages – simplify very detailed data to extremely 
simplified coding and could not analyse the data to its best. Future 
research of a similar scope might choose to make use of less data, but 
explore it in more detail.
4. Geographical limitation to mainly the Netherlands and Europe – test 
validity at other locations: This study investigated a single case in 
the Netherlands. Throughout the case dutchmen and Germans were 
consulted. some international opinions were recorded at the European 
venture contest in denmark, but this still is very limited. To generalise 
the results to a broader geographic area, cases across a wide geographical 
spread have to be investigated.
5. Involve end-users in research: Here no discussions with the end-users of 
the Avs or other medical products were hold. The patient of the medical 
might – as much as the investor – be influenced by the existence of a 
patent. This is an aspect that should be covered in future investigations.
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